Acute Kidney Injury News

Mitochondrial transplantation may be effective in mitigating or reversing kidney damage, according to study results from researchers at the Wake Forest University School of Medicine.

Researchers funded by the NIH developed a comprehensive atlas of the human kidney to examine disease progression and recovery.

The link between mild-to-moderate acute kidney injury and subsequent worsening kidney function was small and not statistically significant in patients with chronic kidney disease, a recent study found.

Researchers identified thresholds for low oxygen delivery leading to acute kidney injury during cardiac surgery that were lower than previously reported.

One in four patients who were critically ill with AKI received proper follow-up care within 3 months after hospital discharge, according to recently published data.

Investigators proposed a way to classify subgroups of patients with AKI using plasma and urine biomarkers, according to research published in the American Journal of Kidney Diseases.

The FDA has granted orphan drug designation to felzartamab, an investigational agent being developed by Human Immunology Biosciences to treat primary membranous nephropathy, according to a press release.

The platelet-to-lymphocyte ratio has potential to be a marker of mortality for patients with AKI, according to data published in Kidney Medicine.

Patients who experience AKI during hospitalization showed an increased risk for 90- and 365-day all-cause and selected-cause rehospitalization and death following discharge, according to data in the American Journal of Kidney Diseases.

Patients who experience AKI during hospitalization showed an increased risk for 90- and 365-day all-cause and selected-cause rehospitalization and death following discharge, according to data in the American Journal of Kidney Diseases.